Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-10T20:39:17.938Z Has data issue: false hasContentIssue false

Chapter 33 - Common rheumatologic diseases in the elderly

from Section III - Care of the elderly by organ system

Published online by Cambridge University Press:  05 June 2016

Jan Busby-Whitehead
Affiliation:
University of North Carolina
Christine Arenson
Affiliation:
Thomas Jefferson University, Philadelphia
Samuel C. Durso
Affiliation:
The Johns Hopkins University School of Medicine
Daniel Swagerty
Affiliation:
University of Kansas
Laura Mosqueda
Affiliation:
University of Southern California
Maria Fiatarone Singh
Affiliation:
University of Sydney
William Reichel
Affiliation:
Georgetown University, Washington DC
Get access

Summary

Rheumatologic disease is often encountered in the geriatric population. Osteoarthritis, rheumatoid arthritis, and crystal-induced arthritis primarily affect the joints. Osteoarthritis, or degenerative arthritis, is the most common joint disease of the elderly. The most common sites include the hands, spine, hip, knees and feet. Rheumatoid arthritis also occurs in the geriatric population. This autoimmune disorder requires early and aggressive treatment to prevent increased morbidity and mortality. Crystal-induced arthritis, mostly gout and pseudogout, has an increased incidence and prevalence in the elderly. Other rheumatologic diseases seen more commonly in the elderly include polymyalgia rheumatica, giant cell arteritis, remitting seronegative symmetrical synovitis with pitting edema, Sjogren’s syndrome, and inclusion body myositis. Polymyalgia rheumatica, an inflammatory disease primarily involving the shoulders and pelvic girdle, is only found in the elderly. Giant cell arteritis, a vasculitis of large vessels, is also only present in the geriatric population. Remitting seronegative symmetrical synovitis with pitting edema is a disease of patients older than 50 years of age.
Type
Chapter
Information
Reichel's Care of the Elderly
Clinical Aspects of Aging
, pp. 453 - 461
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Deal, CL, Hooker, R, Harrington, T, et al. The United States rheumatology workforce: supply and demand, 2005–2025. Arthritis Rheum. 2007; 56(3): 722729.Google Scholar
Murray, CJL, Vos, T, Lozano, R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 21972223.Google Scholar
Lawrence, RC, Felson, DT, Helmick, CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum. 2008; 58(1): 2635.Google Scholar
Neogi, T, Zhang, Y. Epidemiology of osteoarthritis. Rheum Dis Clic of N Amer. 2013; 39(1): 119.Google Scholar
Blagojevic, M, Jinks, C, Jeffery, A, Jordan, KP. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis and cartilage. 2010; 18(1): 2433.Google Scholar
Roddy, E, Zhang, W, Doherty, M. Prevalence and associations of hallux valgus in a primary care population. Arthritis Care Res. 2008; 59(6): 857862.Google Scholar
Villareal, DT, Chode, S, Parimi, N, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011; 364(13):12181229.Google Scholar
Towheed, T, Maxwell, L, Judd, M, et al. Acetaminophen for osteoarthritis. Available at: http://summaries.cochrane.org/CD004257/acetaminophen-for-osteoarthritis (accessed 19 June 2014).Google Scholar
The Acetaminophen Hepatotoxicity Working Group. Recommendations for FDA Interventions to Decrease the Occurrence of Acetaminophen Hepatotoxicity. 2008 Available at: www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm161518.pdf (accessed 20 December 2014).Google Scholar
Underwood, M, Ashby, D, Cross, P et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomized controlled trial and patient preference study. BMJ. 2008; 336:138142.Google Scholar
Rolita, L, Spegman, A, Tang, X, Cronstein, BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. Jour Am Ger Soc. 2013; 61(3): 335340.Google Scholar
Raynauld, JP, Buckland-Wright, C, Ward, R, et al. Safety and efficacy of long‐term intraarticular steroid injections in osteoarthritis of the knee: A randomized, double‐blind, placebo‐controlled trial Arthritis Rheum. 2003; 48(2): 370377.Google Scholar
Bannura, RR, Vaysbrot, EE, Sullivan, MC, et al. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis; a systemic review and meta-analysis. Sem Arthritis and Rheum. 2014; 43: 593599.Google Scholar
Rasch, EK, Hirsch, R, Paulose-Ram, R, Hochberg, MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum. 2003; 48(4): 917926.Google Scholar
Innala, L, Moller, B, Ljung, L, Smedby, T, Södergren, A, Magnusson, S, et al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis. Arthritis Rheum. 2012; 64(10): S908.Google Scholar
O’Dell, JR, Mikuls, TR, Taylor, TH, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. (2103); 369(4): 307318.CrossRefGoogle Scholar
Ornetti, P, Chevillotte, H, Zerrak, A, Maillefert, JF. Anti-tumour necrosis factor-α therapy for rheumatoid and other inflammatory arthropathies. Drugs Aging. 2006; 23(11): 855860.Google Scholar
Roddy, F, Mallen, CD, Doherty, M. Gout. BMJ 2013; 1347: f5648. doi:10.1136/bmj.f5648.Google Scholar
Campion, EW, Glynn, RJ, DeLabry, LO. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med. 1987; 82: 421426.Google Scholar
Crofford, LJ. Use of NSAIDs in treating patients with arthritis. Arth Res Ther. 2013; 15 (Supplement 3): S2.Google Scholar
Shoji, A, Yamanaka, H, Kamatani, N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004; 51: 321325.Google Scholar
Hande, RK, Noone, RM, Stone, WJ. Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984; 76: 4756.Google Scholar
Stamp, LK, O’Donnell, JL, Zhang, M, et al. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Arthritis Rheum. 2012; 63(2): 412421.Google Scholar
Wilkins, E, Dieppe, P, Maddison, P, Evison, G. Osteoarthritis and articular chondrocalcinosis in the elderly. Annals Rheum Dis. 1983; 42(3): 280284.Google Scholar
Terkeltaub, RA. Colchicine update: 2008. Sem arthritis rheum. 2008; 38(6): 411419.CrossRefGoogle ScholarPubMed
Doran, MF, Crowson, CS, O’Fallon, WM, et al. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheum. 2002; 29(8): 16941697.Google Scholar
Gonzalez‐Gay, MA, Vazquez‐Rodriguez, TR, Lopez‐Diaz, MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Care Res. 2009; 61(10): 14541461.Google Scholar
Gonzalez-Gay, MA, Rodriiguez-Valverde, V, Blanco, R, et al. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate: a more benign syndrome. Arch Int Med. 1997; 157(3): 317320.Google Scholar
Camellino, D, Cimmino, MA. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Rheumatology 2012; 51(1): 7786.Google Scholar
Weyland, CM, Goronzy, JJ. Giant cell arteritis and polymyalgia rheumatic. N Engl J Med. 2014; 371: 5057.Google Scholar
Kermani, TA., Schäfer, VS, Crowson, CS, et al. Increase in age at onset of giant cell arteritis: a population-based study. Annals Rheum Dis. 2010; 69(4): 780781.Google Scholar
Prieto-González, S, Arguis, P, García-Martínez, A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Annals Rheum Dis. 2012; 71(7): 11701176.Google Scholar
Salvarani, C, Hunder, GG. Giant cell arteritis with low erythrocyte sedimentation rate: Frequency of occurrence in a population‐based study. Arthritis Care Res. 2010; 45(2): 140145.Google Scholar
Nesher, G. The diagnosis and classification of giant cell arteritis. J Autoimmunity. 2014; 48: 7375.Google Scholar
Klauser, A, Frauscher, F, Halpern, EJ, et al. Remitting seronegative symmetrical synovitis with pitting edema of the hands: ultrasound, color doppler ultrasound, and magnetic resonance imaging findings. Arthritis Care Res. 2005; 53(2): 226233.Google Scholar
Moerman, RV, Bootsma, H, Kroese, FG, Vissink, A. Sjögren’s syndrome in older patients. Drugs & Aging. 2013; 30(3): 137153.Google Scholar
Theander, E, Henriksson, G, Ljungberg, O, et al. Lymphoma and other malignancies in primary Sjögren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Annals Rheum Dis. 2006; 65(6): 796803.Google Scholar
Wilson, FC, Ytterberg, SR, St Sauver, JL, Reed, AM. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheum. 2008; 35(3): 445447.Google Scholar
Greenberg, SA. Inclusion body myositis. Current Opinion Rheum. 2011; 23(6): 574578.Google Scholar
Griggs, RC. The current status of treatment for inclusion body myositis. Neurology. 2006; 66(2 Suppl 1): S30S32.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×